Kettle Hill Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-41,906
| Closed | -$336K | – | 50 |
|
|
2024
Q2 | $336K | Buy |
+41,906
| New | +$336K | 0.08% | 47 |
|
|
2023
Q4 | – | Sell |
-38,474
| Closed | -$175K | – | 48 |
|
|
2023
Q3 | $175K | Buy |
+38,474
| New | +$175K | 0.04% | 37 |
|
|
2023
Q1 | – | Sell |
-96,007
| Closed | -$613K | – | 69 |
|
|
2022
Q4 | $613K | Buy |
+96,007
| New | +$613K | 0.12% | 43 |
|
|
2022
Q3 | – | Sell |
-81,958
| Closed | -$905K | – | 76 |
|
|
2022
Q2 | $905K | Buy |
+81,958
| New | +$905K | 0.23% | 45 |
|